Atrial fibrillation and ischemic events with rivaroxaban in patients with stable coronary artery disease (AFIRE): Protocol for a multicenter, prospective, randomized, open-label, parallel group study-Reference-Cited by-同舟云学术

Atrial fibrillation and ischemic events with rivaroxaban in patients with stable coronary artery disease (AFIRE): Protocol for a multicenter, prospective, randomized, open-label, parallel group study

Published:2018-08 Issue: Volume:265 Page:108-112
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Yasuda Satoshi,Kaikita Koichi,Ogawa Hisao,Akao Masaharu,Ako Junya,Matoba Tetsuya,Nakamura Masato,Miyauchi Katsumi,Hagiwara Nobuhisa,Kimura Kazuo,Hirayama Atsushi,Matsui Kunihiko

Funder

Bayer Yakuhin, Ltd.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study;Toyoda;Stroke,2008

2. Impact of anticoagulant therapy with dual antiplatelet therapy on prognosis after treatment with drug-eluting coronary stents;Uchida;J. Cardiol.,2010

3. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Eur. Heart J.,2016

4. Impact of coronary computed tomography angiography findings on initiation of cardioprotective medications;Chang;Circ. J.,2017

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between thromboembolic risk and prevalence of coronary artery disease in patients with atrial fibrillation and impaired renal function;IJC Heart & Vasculature;2024-08

2. Antithrombotic therapy for stable coronary artery disease and atrial fibrillation in patients with and without revascularisation: the AFIRE trial;EuroIntervention;2024-04

3. Long-term prognostic significance of history of cancer and atrial fibrillation in coronary artery disease;IJC Heart & Vasculature;2023-12

4. Risk prediction score for clinical outcome in atrial fibrillation and stable coronary artery disease;Open Heart;2023-05

5. Rivaroxaban Monotherapy in Atrial Fibrillation and Stable Coronary Artery Disease Across Body Mass Index Categories;JACC: Asia;2022-12